JP2001505782A5 - - Google Patents

Download PDF

Info

Publication number
JP2001505782A5
JP2001505782A5 JP1998526956A JP52695698A JP2001505782A5 JP 2001505782 A5 JP2001505782 A5 JP 2001505782A5 JP 1998526956 A JP1998526956 A JP 1998526956A JP 52695698 A JP52695698 A JP 52695698A JP 2001505782 A5 JP2001505782 A5 JP 2001505782A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998526956A
Other languages
English (en)
Other versions
JP2001505782A (ja
JP4015201B2 (ja
Filing date
Publication date
Priority claimed from US08/982,272 external-priority patent/US7070771B1/en
Application filed filed Critical
Publication of JP2001505782A publication Critical patent/JP2001505782A/ja
Publication of JP2001505782A5 publication Critical patent/JP2001505782A5/ja
Application granted granted Critical
Publication of JP4015201B2 publication Critical patent/JP4015201B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

Figure 2001505782
Figure 2001505782
Figure 2001505782
Figure 2001505782
Figure 2001505782
JP52695698A 1996-12-09 1997-12-08 補助分子リガンド遺伝子を含む新規な発現ベクター、ならびに免疫調節のためのならびに悪性腫瘍および自己免疫疾患の処置のためのその用途 Expired - Fee Related JP4015201B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US3214596P 1996-12-09 1996-12-09
US60/032,145 1996-12-09
US08/982,272 US7070771B1 (en) 1996-12-09 1997-12-01 Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
US08/982,272 1997-12-01
PCT/US1997/022740 WO1998026061A2 (en) 1996-12-09 1997-12-08 Expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease

Publications (3)

Publication Number Publication Date
JP2001505782A JP2001505782A (ja) 2001-05-08
JP2001505782A5 true JP2001505782A5 (ja) 2005-08-11
JP4015201B2 JP4015201B2 (ja) 2007-11-28

Family

ID=26708033

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52695698A Expired - Fee Related JP4015201B2 (ja) 1996-12-09 1997-12-08 補助分子リガンド遺伝子を含む新規な発現ベクター、ならびに免疫調節のためのならびに悪性腫瘍および自己免疫疾患の処置のためのその用途

Country Status (16)

Country Link
US (3) US7070771B1 (ja)
EP (4) EP0948614B1 (ja)
JP (1) JP4015201B2 (ja)
CN (1) CN1221662C (ja)
AT (2) ATE547524T1 (ja)
AU (1) AU5795798A (ja)
BR (1) BR9714004A (ja)
CA (2) CA2274498C (ja)
DE (1) DE69739220D1 (ja)
DK (1) DK0948614T3 (ja)
ES (1) ES2321246T3 (ja)
IL (3) IL130247A0 (ja)
NO (2) NO327411B1 (ja)
NZ (1) NZ336092A (ja)
PT (1) PT948614E (ja)
WO (1) WO1998026061A2 (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7070771B1 (en) * 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
JP2003508016A (ja) * 1999-04-16 2003-03-04 エフ．ホフマン−ラ ロシュ アーゲー Ｃｄ４０／ｃｄ４０ｌキメラポリペプチドをコードする核酸、それらの生成方法及びそれらの使用
GB9917180D0 (en) * 1999-07-23 1999-09-22 Univ Sheffield Cell surface receptor
GB0025307D0 (en) * 2000-10-16 2000-11-29 Celltech Chiroscience Ltd Biological products
AU2002221780A1 (en) * 2000-10-31 2002-05-15 F.Hoffmann-La Roche Ag Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof
US7786282B2 (en) * 2001-12-06 2010-08-31 The Regents Of The University Of California Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
WO2003070271A2 (en) * 2002-02-25 2003-08-28 Isis Innovation Limted Novel complexes for inducing an immune response
US7495090B2 (en) * 2002-05-23 2009-02-24 The Regents Of The University Of California Nucleic acids encoding chimeric CD154 polypeptides
US7435596B2 (en) 2004-11-04 2008-10-14 St. Jude Children's Research Hospital, Inc. Modified cell line and method for expansion of NK cell
US20130266551A1 (en) 2003-11-05 2013-10-10 St. Jude Children's Research Hospital, Inc. Chimeric receptors with 4-1bb stimulatory signaling domain
US20080044393A1 (en) * 2004-07-16 2008-02-21 White Robert L Retinal dystrophin transgene and methods of use thereof
EP2139913A4 (en) * 2007-03-08 2011-09-21 Mayo Foundation INDUCTION OF TUMOR CELL DEATH THROUGH IMMUNE
US20100050276A1 (en) * 2008-08-22 2010-02-25 Brown University Transgenic non-human animal models of apoptosis-mediated conditions
EP2788021B1 (en) 2011-12-09 2017-01-18 Bavarian Nordic A/S Poxvirus vector for the expression of bacterial antigens linked to tetanus toxin fragment c
RS58122B1 (sr) * 2012-10-17 2019-02-28 Vascular Biogenics Ltd Adenovirus koji eksprimira fas-himer i njegova upotreba u postupcima lečenja kancera
WO2015148879A1 (en) * 2014-03-27 2015-10-01 The Regents Of The University Of Michigan Cancer immunotherapy compositions and methods
AU2015259877B2 (en) 2014-05-15 2021-02-25 National University Of Singapore Modified natural killer cells and uses thereof
CN105567679B (zh) * 2014-10-10 2019-07-05 深圳市北科生物科技有限公司 可分泌型trail蛋白构建物和表达载体
WO2017079297A1 (en) 2015-11-02 2017-05-11 Memgen Llc Methods for treatment of cancer
US11298420B2 (en) 2016-12-21 2022-04-12 Memgen, Llc Armed oncolytic viruses
CN117384929A (zh) 2017-03-27 2024-01-12 新加坡国立大学 一种编码由细胞表达的嵌合受体的多核苷酸
CN113766956B (zh) 2019-03-05 2024-05-07 恩卡尔塔公司 Cd19定向性嵌合抗原受体及其在免疫疗法中的用途
CN112725379B (zh) * 2021-01-27 2024-08-13 上海南方模式生物科技股份有限公司 人源化cd40基因改造动物模型的构建方法及应用
US11585330B1 (en) * 2021-09-29 2023-02-21 Halliburton Energy Services, Inc. Flow control for geothermal well

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3750056T2 (de) 1986-06-20 1995-04-06 Dainippon Pharmaceutical Co Polypeptid-Mutanten des menschlichen TNF und für diese Mutanten codierende DNS.
EP0317641B1 (en) 1987-05-29 1993-03-17 Sagami Chemical Research Center Fused protein containing lymphotoxin
JP2930713B2 (ja) 1989-08-16 1999-08-03 カイロン コーポレイション タンパク質ホルモン形成の抑制用の組成物およびその使用法
US5519119A (en) 1990-09-21 1996-05-21 Ishihara Sangyo Kaisha Ltd. Muteins of TNF pharmaceutical compositions and a method of making
CA2055168A1 (en) 1990-11-21 1992-05-22 Walter Fiers Tnf-muteins
DK0667901T4 (da) 1991-10-25 2008-11-10 Immunex Corp Hidtil ukendt cytokin
EP0670730B1 (en) 1992-03-30 2003-06-04 Immunex Corporation Fusion protein comprising two tumor necrosis factor receptors
SK376492A3 (en) 1992-04-02 1995-06-07 Hoffmann La Roche Tnf - muteins and method of their production
DK0615451T3 (da) 1992-05-26 2006-04-24 Immunex Corp Hidtil ukendt cytokin der binder til CD30
AU5098493A (en) 1992-08-21 1994-03-15 Schering Corporation Cd40 ligand, anti cd40 antibodies, and soluble cd40
JPH07508179A (ja) 1992-08-21 1995-09-14 シェリング・コーポレーション ヒトインターロイキン−１３
US5540926A (en) 1992-09-04 1996-07-30 Bristol-Myers Squibb Company Soluble and its use in B cell stimulation
US5573924A (en) 1992-09-08 1996-11-12 Immunex Corporation CD27 ligand
US5565321A (en) 1993-01-22 1996-10-15 Immunex Corporation Detection of mutations in a CD40 ligand gene
ES2211876T3 (es) 1993-01-22 2004-07-16 Immunex Corporation Deteccion y tratamiento de mutaciones en un gel del ligando de cd40.
US5830463A (en) 1993-07-07 1998-11-03 University Technology Corporation Yeast-based delivery vehicles
US5861310A (en) * 1993-11-03 1999-01-19 Dana-Farber Cancer Institute Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor
JPH08127594A (ja) 1993-11-10 1996-05-21 Mochida Pharmaceut Co Ltd Ｆａｓ抗原に結合する新規蛋白質およびそれをコードするＤＮＡ
AU1059095A (en) * 1993-11-24 1995-06-13 Australian National University, The Treatment of viral disease with cd40l peptide
PT751781E (pt) 1993-12-23 2004-09-30 Nat Inst Of Health As Repr By Utilizacao de anticorpos monoclonais ou ligandos oligomericos soluveis no fabrico de um medicamento para a prevencao ou tratamento de desordens neoplasicas
EP0739350B1 (en) 1994-01-07 2008-02-27 Mochida Pharmaceutical Co., Ltd. Ligand that binds fas antigen
DK0763057T3 (da) 1994-04-28 2006-03-27 Boehringer Ingelheim Pharma Fremgangsmåde til proliferering og differentiering af B celler og anvendelse deraf
US5606023A (en) 1994-05-24 1997-02-25 Thomas Jefferson University Mutant tumor necrosis factor proteins
US5759536A (en) 1994-05-27 1998-06-02 University Technology Corporation Use of fas ligand to supress T-lymphocyte-mediated immune responses
BR9508419A (pt) 1994-07-22 1997-11-18 Hoffmann La Roche Composições farmacêuticas compreendendo uma proteina de ligação de tnf quinerica
GB9425060D0 (en) 1994-12-13 1995-02-08 Univ Birmingham Carcinoma treatment
US5888764A (en) * 1995-01-20 1999-03-30 Uab Research Foundation Human fas gene promoter region
US6017527A (en) * 1996-07-10 2000-01-25 Immunex Corporation Activated dendritic cells and methods for their activation
US6544523B1 (en) 1996-11-13 2003-04-08 Chiron Corporation Mutant forms of Fas ligand and uses thereof
US7070771B1 (en) * 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
US6016832A (en) * 1997-04-16 2000-01-25 Woodward Governor Company Valve for controlling gas mass flow
JP4162849B2 (ja) 1997-09-17 2008-10-08 持田製薬株式会社 新規Ｆａｓリガンド誘導体
US7786282B2 (en) * 2001-12-06 2010-08-31 The Regents Of The University Of California Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
US7495090B2 (en) * 2002-05-23 2009-02-24 The Regents Of The University Of California Nucleic acids encoding chimeric CD154 polypeptides
GB2392158B (en) * 2002-08-21 2005-02-16 Proimmune Ltd Chimeric MHC protein and oligomer thereof

Similar Documents

Publication Publication Date Title
JP2000502280A5 (ja)
JP2000501771A5 (ja)
JP2000501599A5 (ja)
JP2000501018A5 (ja)
JP2000500076A5 (ja)
JP2000501324A5 (ja)
JP2000500055A5 (ja)
JP2000501338A5 (ja)
JP2000502472A5 (ja)
JP2000501825A5 (ja)
JP2000500874A5 (ja)
JP2000502485A5 (ja)
JP2000502425A5 (ja)
JP2000501774A5 (ja)
JP2000502570A5 (ja)
JP2000502568A5 (ja)
JP2000500912A5 (ja)
JP2000501876A5 (ja)
JP2000501744A5 (ja)
JP2000502316A5 (ja)
JP2000501229A5 (ja)
JP2000500857A5 (ja)
JP2000502714A5 (ja)
JP2000501569A5 (ja)
JP2000500318A5 (ja)